XML 80 R64.htm IDEA: XBRL DOCUMENT v3.24.2

Long-Term Investment (Details)	12 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2024 CNY (¥)	Mar. 31, 2023 USD ($)	Mar. 31, 2021 USD ($)
Long-Term Investment [Line Items]
Investment percentage	8.00%
Injected funds	$ 1,113,650	¥ 8,000,000
Impairment loss			$ 1,607,537
Kahamadi Bio [Member]
Long-Term Investment [Line Items]
Investment percentage	49.00%
Suffered loss	$ 0		0
Zhuoli Service [Member]
Long-Term Investment [Line Items]
Investment percentage	39.00%
Suffered loss			2,402,376
Jiuzhou Pharmacy [Member]
Long-Term Investment [Line Items]
Injected funds				$ 1,443,752
Songlu Pharmaceutical [Member]
Long-Term Investment [Line Items]
Investment percentage	0.37%
Zhejiang Jiuzhou Digital Medicine Technology Co., LTD [Member]
Long-Term Investment [Line Items]
Investment percentage	25.92%
Jiuzhou Digital [Member]
Long-Term Investment [Line Items]
Injected funds			$ 4,379

X

- References

No definition available.

+ Details

Name:	cjjd_InjectedFunds
Namespace Prefix:	cjjd_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Investment percentage.

+ References

No definition available.

+ Details

Name:	cjjd_InvestmentPercentage
Namespace Prefix:	cjjd_
Data Type:	dtr:percentItemType
Balance Type:	na
Period Type:	instant

X

- References

No definition available.

+ Details

Name:	cjjd_LongTermInvestmentDetailsLineItems
Namespace Prefix:	cjjd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Long-term investment impairment loss.

+ References

No definition available.

+ Details

Name:	cjjd_LongTermInvestmentImpairmentLoss
Namespace Prefix:	cjjd_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Amount of gain (loss) on sale or disposal of an equity method investment.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(9)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(7)(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 28
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-28

+ Details

Name:	us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_LongtermDebtTypeAxis=cjjd_KahamadiBioMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_LongtermDebtTypeAxis=cjjd_ZhuoliServiceMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_LongtermDebtTypeAxis=cjjd_EntityFiveMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_LongtermDebtTypeAxis=cjjd_SongluPharmaceuticalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_LongtermDebtTypeAxis=cjjd_ZhejiangJiuzhouDigitalMedicineTechnologyCoLTDMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_LongtermDebtTypeAxis=cjjd_JiuzhouDigitalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: